Skip to main content
Clinical Trials/IRCT20151205025372N3
IRCT20151205025372N3
Recruiting
Phase 3

Comparison of clinical outcomes of treatment with cefepime monotherapy vs aminoglycoside-ceftriaxone combination in children with chemotherapy induced fever and neutropenia

Oroumia University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Oroumia University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Oroumia University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age between 3 months to 18 years
  • Diagnosis of fever and neutropenia (oral temperature \= 38\.3 at one measurement or \=38 temperature that lasts for one hour, with ANC \<500 )
  • Consent of the parent or legal guardian to participate in the study protocol
  • No contraindications for receiving the studied antibiotics (gentamicin, amikacin, ceftriaxone, cefepime)

Exclusion Criteria

  • Patients with a history of type 1 allergy to one of the above antibiotics
  • Patients who have a positive culture with specific microorganism on admission
  • Patients in need who need extensive antibiotic coverage from the beginning of hospitalization

Outcomes

Primary Outcomes

Not specified

Similar Trials